Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cencora Inc (COR)

Cencora Inc (COR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 68,838,416
  • Shares Outstanding, K 193,993
  • Annual Sales, $ 321,333 M
  • Annual Income, $ 1,554 M
  • EBIT $ 4,404 M
  • EBITDA $ 5,472 M
  • 60-Month Beta 0.66
  • Price/Sales 0.21
  • Price/Cash Flow 16.44
  • Price/Book 39.45

Options Overview Details

View History
  • Implied Volatility 28.35% (+1.21%)
  • Historical Volatility 15.23%
  • IV Percentile 87%
  • IV Rank 53.67%
  • IV High 36.68% on 04/08/25
  • IV Low 18.69% on 02/18/25
  • Expected Move (DTE 33) 21.58 (6.08%)
  • Put/Call Vol Ratio 0.09
  • Today's Volume 239
  • Volume Avg (30-Day) 719
  • Put/Call OI Ratio 0.62
  • Today's Open Interest 33,436
  • Open Int (30-Day) 31,911
  • Expected Range 333.27 to 376.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 4.04
  • Number of Estimates 6
  • High Estimate 4.39
  • Low Estimate 3.89
  • Prior Year 3.73
  • Growth Rate Est. (year over year) +8.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
329.10 +7.82%
on 01/05/26
356.86 -0.56%
on 01/16/26
+13.13 (+3.84%)
since 12/16/25
3-Month
319.37 +11.11%
on 10/17/25
377.54 -6.01%
on 11/25/25
+35.45 (+11.10%)
since 10/16/25
52-Week
237.71 +49.28%
on 02/18/25
377.54 -6.01%
on 11/25/25
+113.96 (+47.31%)
since 01/16/25

Most Recent Stories

More News
What to Expect From Cencora's Next Quarterly Earnings Report

Cencora is set to report its first-quarter earnings next month, and analysts are anticipating a single-digit increase in its bottom line.

XLV : 155.74 (-0.78%)
$SPX : 6,940.01 (-0.06%)
COR : 354.85 (-0.14%)
3 Healthcare Stocks with Exciting Potential

3 Healthcare Stocks with Exciting Potential

COR : 354.85 (-0.14%)
PODD : 287.70 (+0.42%)
ABBV : 214.35 (-0.31%)
Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release

Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the First Quarter of Fiscal 2026 on Wednesday, February 4, 2026, prior to the opening of trading on the New York Stock...

COR : 354.85 (-0.14%)
2 Large-Cap Stocks Worth Your Attention and 1 We Question

2 Large-Cap Stocks Worth Your Attention and 1 We Question

CVS : 78.60 (-3.39%)
COR : 354.85 (-0.14%)
TEAM : 118.55 (-7.71%)
Q3 Rundown: Cencora (NYSE:COR) Vs Other Health Insurance Providers Stocks

Q3 Rundown: Cencora (NYSE:COR) Vs Other Health Insurance Providers Stocks

COR : 354.85 (-0.14%)
2 Large-Cap Stocks Worth Investigating and 1 We Find Risky

2 Large-Cap Stocks Worth Investigating and 1 We Find Risky

AMAT : 327.01 (+2.49%)
INTU : 545.29 (-1.68%)
COR : 354.85 (-0.14%)
Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology

Company reiterates fiscal 2026 guidance Company raises long-term guidance expectations to reflect OneOncology’s expected long-term contribution to enterprise...

COR : 354.85 (-0.14%)
Is Cardinal Health Stock Outperforming the Nasdaq?

Cardinal Health has outperformed the broader Nasdaq index over the past year. Moreover, Wall Street analysts remain strongly optimistic about its prospects.

$NASX : 23,515.39 (-0.06%)
COR : 354.85 (-0.14%)
CAH : 212.45 (-0.47%)
1 S&P 500 Stock to Own for Decades and 2 That Underwhelm

1 S&P 500 Stock to Own for Decades and 2 That Underwhelm

DHI : 155.96 (-3.13%)
COR : 354.85 (-0.14%)
GPC : 136.94 (+0.57%)
Why Cencora (COR) Shares Are Trading Lower Today

Why Cencora (COR) Shares Are Trading Lower Today

COR : 354.85 (-0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.

See More

Key Turning Points

3rd Resistance Point 361.45
2nd Resistance Point 359.16
1st Resistance Point 357.00
Last Price 354.85
1st Support Level 352.56
2nd Support Level 350.27
3rd Support Level 348.11

See More

52-Week High 377.54
Last Price 354.85
Fibonacci 61.8% 324.12
Fibonacci 50% 307.63
Fibonacci 38.2% 291.13
52-Week Low 237.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar